BioMarin Pharmaceutical
BMRN
#1984
Rank
โ‚ฌ8.97 B
Marketcap
46,68ย โ‚ฌ
Share price
0.44%
Change (1 day)
-8.38%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: โ‚ฌ8.97 Billion

As of April 2026 BioMarin Pharmaceutical has a market cap of โ‚ฌ8.97 Billion. This makes BioMarin Pharmaceutical the world's 1984th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ8.97 B-8.44%
2025โ‚ฌ9.80 B-19.97%
2024โ‚ฌ12.25 B-25.44%
2023โ‚ฌ16.42 B-8.37%
2022โ‚ฌ17.93 B25.19%
2021โ‚ฌ14.32 B10.67%
2020โ‚ฌ12.94 B-4.65%
2019โ‚ฌ13.57 B2.3%
2018โ‚ฌ13.26 B1.66%
2017โ‚ฌ13.05 B-3.64%
2016โ‚ฌ13.54 B-12.48%
2015โ‚ฌ15.47 B39.65%
2014โ‚ฌ11.08 B51.64%
2013โ‚ฌ7.30 B56.18%
2012โ‚ฌ4.67 B54.76%
2011โ‚ฌ3.02 B34.99%
2010โ‚ฌ2.23 B68.98%
2009โ‚ฌ1.32 B4.29%
2008โ‚ฌ1.27 B-46.02%
2007โ‚ฌ2.35 B106.65%
2006โ‚ฌ1.13 B68.51%
2005โ‚ฌ0.67 B122.53%
2004โ‚ฌ0.30 B-23.16%
2003โ‚ฌ0.39 B9.02%
2002โ‚ฌ0.36 B-54.52%
2001โ‚ฌ0.79 B110.03%
2000โ‚ฌ0.37 B-6.65%
1999โ‚ฌ0.40 B

End of Day market cap according to different sources

On Apr 19th, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

โ‚ฌ8.93 Billion
by Nasdaq info icon info icon
โ‚ฌ8.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚ฌ97.78 B 989.34%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚ฌ2.09 B-76.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ95.16 M-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.44 B-95.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ3.86 B-56.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ2.72 B-69.64%๐Ÿ‡บ๐Ÿ‡ธ USA